Tickerplace logo

Tickerplace

BCAL Diagnostics Limited logo

BDXBCAL Diagnostics Limited

BDX Stock Price, Valuation & Chart | BCAL Diagnostics Limited

Compare
$0.080+0.00 (+0.00%)

At close · 15 Oct 2026, 04:26 am

Sector: HealthcareWebsite
OverviewFinancialsDividendsRatios

BDX Historical price chart

BDX Key Stats

Market Capitalization29.13M
PE Ratio-3.97
EPS-0.02
Trading Volume45.13K
Today's High/Low0.08/0.08
Dividend Yield0.00
52 Week High/Low0.15/0.05
Shares Outstanding368.68M
BDX Financial Statement

BDX Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to BDX in the past 3 months.

BDX Analysis & performance metrics

BDX Company profile

BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a…

BDX Management team

Management
Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICDCFO
Chief Financial Officer & Company Secretary
Sean KennedyCTO
Director of Corporate Finance
Jayne Andrea Shaw
Co-Founder & Executive Chairman
Shane Ryan M.B.A.CEO
Chief Executive Officer
Hon. Ronald Anthony Phillips A.O.CTO
Co-Founder & Non-Executive Director
Total 5 executives

BDX Frequently asked questions

What is BCAL Diagnostics Limited (BDX) Stock Price?

Current stock price of BCAL Diagnostics Limited (BDX) stock is $0.080. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of BCAL Diagnostics Limited (BDX) stock is 45.13K.

Last updated at 15 Oct 2026, 04:26 am.

Why is the BCAL Diagnostics Limited (BDX) stock price going up or down today?

The stock price of BCAL Diagnostics Limited (BDX) can change with earnings, company news, and overall market sentiment. BCAL Diagnostics Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BCAL Diagnostics Limited stock expensive at its current price?

Whether BCAL Diagnostics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BDX on this page is -3.97. EPS on this page is -0.02. Compare those figures with peers and growth expectations before deciding if the current BCAL Diagnostics Limited price is justified.

How has the stock price of BCAL Diagnostics Limited (BDX) performed historically?

Historical performance for BCAL Diagnostics Limited (BDX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BDX reacted to past earnings and market events.

Should I buy BCAL Diagnostics Limited (BDX) stock, at this price?

Buying BCAL Diagnostics Limited (BDX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.